NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.76
-0.14 (-0.94%)
At close: Sep 8, 2026, 4:00 PM EDT
14.76
0.00 (0.00%)
After-hours: Sep 8, 2026, 4:10 PM EDT
NeuroPace Revenue
NeuroPace had revenue of $22.83M in the quarter ending June 30, 2026, with 17.05% growth. This brings the company's revenue in the last twelve months to $98.84M, up 16.90% year-over-year. In the year 2025, NeuroPace had annual revenue of $99.99M with 25.13% growth.
Revenue (ttm)
$98.84M
Revenue Growth
+16.90%
P/S Ratio
4.77
Revenue / Employee
$486,332
Employees
220
Market Cap
506.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 99.99M | 20.08M | 25.13% |
| Dec 31, 2024 | 79.91M | 14.49M | 22.14% |
| Dec 31, 2023 | 65.42M | 19.90M | 43.72% |
| Dec 31, 2022 | 45.52M | 337.00K | 0.75% |
| Dec 31, 2021 | 45.18M | 4.05M | 9.83% |
| Dec 31, 2020 | 41.14M | 4.17M | 11.27% |
| Dec 31, 2019 | 36.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tactile Systems Technology | 350.31M |
| OrthoPediatrics | 252.72M |
| Cerus | 221.55M |
| Cytek Biosciences | 206.71M |
| Pacific Biosciences of California | 159.27M |
| Delcath Systems | 95.42M |
| Sight Sciences | 83.38M |
| BrainsWay | 60.70M |
NPCE News
- 8 hours ago - NeuroPace Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 6 days ago - NeuroPace to Participate in 2026 Cantor Global Healthcare Conference - Business Wire
- 8 days ago - NeuroPace to Participate in Wells Fargo 21st Annual Healthcare Conference - Business Wire
- 4 weeks ago - NeuroPace Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - NeuroPace Earnings release: Q2 2026 - Filings
- 4 weeks ago - NeuroPace Quarterly report: Q2 2026 - Filings
- 4 weeks ago - NeuroPace Slides: Q2 2026 - Filings
- 4 weeks ago - NeuroPace reports Q2 EPS (18c), consensus (20c) - TheFly